Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
2 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Targeting the dendritic cell-T cell axis to develop effective immunotherapies for glioblastoma.
Front Immunol. 2023 Oct 20;14:1261257. doi: 10.3389/fimmu.2023.1261257. eCollection 2023.
Front Immunol. 2023.
PMID: 37928547
Free PMC article.
Review.
Safety and biological outcomes following a phase 1 trial of GD2-specific CAR-T cells in patients with GD2-positive metastatic melanoma and other solid cancers.
Gargett T, Truong NTH, Gardam B, Yu W, Ebert LM, Johnson A, Yeo ECF, Wittwer NL, Tapia Rico G, Logan J, Sivaloganathan P, Collis M, Ruszkiewicz A, Brown MP.
Gargett T, et al. Among authors: gardam b.
J Immunother Cancer. 2024 May 15;12(5):e008659. doi: 10.1136/jitc-2023-008659.
J Immunother Cancer. 2024.
PMID: 38754916
Free PMC article.
Clinical Trial.
Item in Clipboard
Cite
Cite